2Patel O, Shulkes A, Baldwin GS. Gastrin-releasing peptide and cancer[J]. Biochim Biophys Acta, 2006,1766 ( 1 ) : 23-41.
3Ogunwobi O,Beales IL. Glycine-extended gastrin stimulates proliferation and inhibits apoptosis in colon cancer cells via cyclo-oxygenase independent pathways [J].Regul Pept, 2006,134 (1) :1-8.
4Colutei R,Blandizzi C,Tanini M,et al. Gastrin promotes human colon cancer cell growth via CCK-2 receptor-mediated cyclooxygenase-2 induction and prostaglandin E2 production [J]. Br J Pharmacol,2005,144(3):338-348.
5Watson SA, Morris TM, McWilliams DF, et al. Potential role of endocrine gastrin in the colonic adenoma carcinoma sequence[J]. Br J Cancer, 2002,87 ( 5 ) : 567-573.
6Goldstein NS, Armin M. Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer Stage IV colon ad implications for a standardized scoring system[J].Cancer, 2001,92 (5):1331-1346.
7Meten-Mucha G, Tawnicka H, Mucha S. The combined effects of proglumide and fluorouracil on the growth of murine colon 38 cancer cells in vitro[J]. Endokrynol Pol, 2005, 56(6) : 933-938.
8Leon J, Lbpez-Cantarero M, Ros E, et al. Selective CCK-A but not CCK-B receptor antagonists inhibit HT-29 eell proliferation:synergism with pharmacologieal levels of melatonin[J].J Pineal Res, 2005,39 (3) : 243-250.
